EcoDrugPlus

Integrin Subunit Alpha 2b

Ensembl ID : ENSRFEG00010005936
Gene Symbol: ITGA2B
1 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSRFEG00010017895
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSRFEG00010003562
Gene Symbol: ITGA5
1 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSRFEG00010014333
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSRFEG00010004509
Gene Symbol: ITGB1
1 Cross references
298 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSRFEG00010009324
Gene Symbol: ITGB3
1 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSRFEG00010011225
Gene Symbol: ITGB5
1 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSRFEG00010005343
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSRFEG00010001861
Gene Symbol: ITGB7
1 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSRFEG00010015208
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSRFEG00010017025
Gene Symbol: ICAM1
1 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSRFEG00010004937
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).